Kugyelka Reka, Kohl Zoltan, Olasz Katalin, Mikecz Katalin, Rauch Tibor A, Glant Tibor T, Boldizsar Ferenc
Department of Immunology and Biotechnology, University of Pécs, Szigeti ut 12, Pécs 7624, Hungary.
Section of Molecular Medicine, Rush University Medical Center, 1735 West Harrison Street, Chicago, IL 60612, USA.
Mediators Inflamm. 2016;2016:6145810. doi: 10.1155/2016/6145810. Epub 2016 Jan 20.
Rheumatoid arthritis (RA) is one of the most common autoimmune disorders characterized by the chronic and progressive inflammation of various organs, most notably the synovia of joints leading to joint destruction, a shorter life expectancy, and reduced quality of life. Although we have substantial information about the pathophysiology of the disease with various groups of immune cells and soluble mediators identified to participate in the pathogenesis, several aspects of the altered immune functions and regulation in RA remain controversial. Animal models are especially useful in such scenarios. Recently research focused on IL-17 and IL-17 producing cells in various inflammatory diseases such as in RA and in different rodent models of RA. These studies provided occasionally contradictory results with IL-17 being more prominent in some of the models than in others; the findings of such experimental setups were sometimes inconclusive compared to the human data. The aim of this review is to summarize briefly the recent advancements on the role of IL-17, particularly in the different rodent models of RA.
类风湿关节炎(RA)是最常见的自身免疫性疾病之一,其特征是各种器官的慢性进行性炎症,最显著的是关节滑膜炎症,可导致关节破坏、预期寿命缩短和生活质量下降。尽管我们已经掌握了大量关于该疾病病理生理学的信息,识别出了参与发病机制的各种免疫细胞群和可溶性介质,但RA中免疫功能改变和调节的几个方面仍存在争议。动物模型在这种情况下特别有用。最近的研究聚焦于IL-17以及IL-17产生细胞在各种炎症性疾病中的作用,如在RA以及不同的RA啮齿动物模型中。这些研究偶尔会得出相互矛盾的结果,IL-17在某些模型中比在其他模型中更突出;与人类数据相比,此类实验设置的结果有时尚无定论。本综述的目的是简要总结IL-17作用方面的最新进展,特别是在不同的RA啮齿动物模型中的进展。